United States · Industrial & Consumer Products · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Athira Pharma, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -110.77% | -2.19% | -2.24% | -2.29% | -2.34% | -2.4% |
|---|---|---|---|---|---|---|
| ROA | -88.52% | -1.65% | -1.65% | -1.65% | -1.65% | -1.65% |
| Total Assets | $58,779.00K | $58,779.00K | $58,779.00K | $58,779.00K | $58,779.00K | $58,779.00K |
| Net Income | -$96,940.00K | -$970.00K | -$970.00K | -$970.00K | -$970.00K | -$970.00K |